Cardiac Safety

For more than 30 years, ERT has been at the forefront of providing comprehensive cardiac safety solutions that are vital to clients' drug safety and testing efforts.

We understand that only the most accurate and regulatory-compliant data can ensure reliable, quality outcomes. At ERT, we work diligently to provide thorough execution, driven by our collaborative process and proprietary Project Assurance methodology — all to bring safe drugs to market faster. 

Cardiac safety is the number one reason for drug withdrawals and labeling challenges. As a result, industry regulations are under increased scrutiny. Companies are constantly tasked to provide quality data that is critical to ensuring the most accurate assessment of a new drug’s cardiac effect.

ERT’s proven Cardiac Safety Solutions offer a centralized process for the collection and standardization of quality ECG data, every time. Centralization not only reduces inconsistencies that may occur from site to site, but also alleviates our clients’ workloads. We simplify ECG data management and analysis, providing our clients with on-demand, real-time access to their data.

Whether you need cardiac safety planning, centralized core lab services or professional consultation for clinical, scientific and regulatory considerations, ERT has hands-on experts and comprehensive solutions ready to meet your needs.

ERT’s experience spans:

• More than 5,000 studies and 605,000 subjects/patients
• Trials in more than 89 countries, over six continents
• Single-center, as well as global, multicenter trials
• US and UK logistics capabilities for a truly international reach
• More than 500 studies and tens of thousands of investigation sites at any time
• Greater than 150 Thorough QT/QTc Trials (TQT) conducted
• Numerous rescue studies, stepping in to provide reliable support when other core labs failed to deliver

For more information please see our website, or contact us.